Biopharmaceuticals
HIV/AIDS
FDA
News Release - September 20, 2011
Mylan's Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
Source: Mylan
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.